The World Health Organization (WHO) has added the first molecular diagnostic test for the Bundibugyo virus disease to its Emergency Use Listing (EUL).
The test detects Bundibugyo virus (BDBV) by identifying its genetic material in blood samples, enabling rapid and accurate diagnosis.
WHO’s Emergency Use Listing (EUL) evaluates the quality, safety, and performance of essential health products during public health emergencies to facilitate their use, particularly in low- and middle-income countries.
On 17 May 2026, WHO declared a Public Health Emergency of International Concern (PHEIC) following an outbreak of Bundibugyo virus disease in the Democratic Republic of the Congo, with cases also reported in Uganda.
About Bundibugyo virus
Bundibugyo virus disease is a severe and often fatal form of Ebola virus disease caused by the Bundibugyo virus (BDBV), one of the Ebola virus species responsible for major human outbreaks.
The virus is a zoonotic pathogen, spreading initially from infected animals to humans, and subsequently through direct contact with the blood, body fluids, or contaminated materials of infected or deceased persons.
Early diagnosis, isolation of cases, infection prevention and control measures, contact tracing, and supportive clinical care are critical for containing outbreaks and reducing mortality.
Source: WHO
CLICK HERE: UPSC PRELIMS & MAINS CURRENT AFFAIRS BASED WEEKLY TEST (ENG & HINDI)
CLICK HERE FOR GS TIMES PRAHAR UPSC GS MAINS TEST SERIES
CLICK HERE: DAILY CURRENT AFFAIRS QUIZ (FOR ALL EXAMINATIONS)
![](https://www.gstimes.in/wp-content/uploads/2024/03/MARCH-2024-GS-TIMES-1ADD.jpg")
